Clinical trial
ReActiv8 Implantable Neurostimulation System for Chronic Low Back Pain
NCT02577354 · Mainstay Medical, Industry · Completed
Key facts
| NCT number | NCT02577354 |
|---|---|
| Title | ReActiv8 Implantable Neurostimulation System for Chronic Low Back Pain |
| Official title | ReActiv8 Implantable Neurostimulation System for Chronic Low Back Pain (ReActiv8-B) |
| Acronym | ReActiv8-B |
| Lead sponsor | Mainstay Medical, Industry |
| Status | Completed |
| Study type | Interventional |
| Conditions | Chronic Low Back Pain |
| Intervention type | Device |
| Interventions | ReActiv8 Implantable Stimulation System (Patient Appropriate Stimulation), ReActiv8 Implantable Stimulation System (Low Stimulation) |
| Enrollment | 204 |
| Start date | Aug 1, 2016 |
| Primary completion | Nov 1, 2018 |
| Completion | Jan 1, 2024 |
| First posted | Oct 16, 2015 |
| Last update posted | Feb 27, 2025 |
| Countries | Australia, Belgium, Netherlands, United Kingdom, United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: